𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CCR6 has a non-redundant role in the development of inflammatory bowel disease

✍ Scribed by Rosa Varona; Vanesa Cadenas; Juana Flores; Carlos Martínez-A.; Gabriel Márquez

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
374 KB
Volume
33
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of diet in the development of infla
Role of diet in the development of inflammatory bowel disease
✍ Christine A. Chapman-Kiddell; Peter S.W. Davies; Lynda Gillen; Graham L. Radford 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

The inflammatory bowel diseases (IBDs) are a group of heterogeneous disorders characterized by acute and chronic inflammatory changes in the small or large bowel, or in both. Increasing incidence and prevalence figures for IBD both in the developed and developing world indicate that environmental fa

Drug development in inflammatory bowel d
Drug development in inflammatory bowel disease: The role of the FDA
✍ Conor Lahiff; Sunanda Kane; Alan C. Moss 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 2 views

All medicinal compounds sold in the United States for inflammatory bowel disease (IBD) are regulated by the Food and Drug Administration (FDA) via a number of regulations dating back to 1906. The primary contemporary role of the FDA is in the assessment of safety and efficacy, and subsequent marketi

Role of growth factors in the developmen
Role of growth factors in the development of lymphangiogenesis driven by inflammatory bowel disease: A review
✍ Pablo M. Linares; Javier P. Gisbert 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

Studies on angiogenesis and lymphangiogenesis have gained special relevance in research into factors potentially influencing the pathogenesis and course of inflammatory bowel disease (IBD). The results of the few existing studies on the distribution and density of lymphatic vessels and blood vessels

Issues in the development of practice gu
Issues in the development of practice guidelines for inflammatory bowel disease
✍ Dr. William J. Tremaine 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB 👁 2 views

## A Practice guidelines for inflammatory bowel disease (IBD) should address the unique needs and challenges of the patients, to improve not only the quality of medical care but also the quality of life.

Melanocortin-derived tripeptide KPV has
Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease
✍ Klaus Kannengiesser; Christian Maaser; Jan Heidemann; Andreas Luegering; Matthia 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB 👁 1 views

Background: Despite some progress in recent years, the options for treating inflammatory bowel disease (IBD) are still dissatisfying, and surgery rates are still high. The anti-inflammatory effects of melanocortin peptides such as alpha-melanocyte-stimulating hormone (␣-MSH) have been described rece

The role of self-efficacy in inflammator
The role of self-efficacy in inflammatory bowel disease management: Preliminary validation of a disease-specific measure
✍ Laurie Keefer; Jennifer L. Kiebles; Tiffany H. Taft 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Background: Inflammatory bowel diseases (IBDs) require selfmanagement skills that may be influenced by self-efficacy (SE). Self-efficacy represents an individual's perception of his or her ability to organize and execute the behaviors necessary to manage disease. The goal of this study was to develo